Kappa Bioscience AS
Kappa Bioscience AS, headquartered in Norway, is a leading player in the global nutraceutical and dietary supplement industry. Founded in 2008, the company has established itself as a pioneer in the development of high-quality vitamin K2 products, catering to health-conscious consumers and businesses alike. With a strong focus on innovation, Kappa Bioscience offers unique formulations that enhance bone and cardiovascular health, setting them apart in a competitive market. Their flagship product, MenaQ7®, is renowned for its superior bioavailability and efficacy, making it a preferred choice among manufacturers and health professionals. Kappa Bioscience's commitment to quality and sustainability has earned them a prominent position in the industry, with a growing presence in Europe, North America, and Asia. Their dedication to research and development continues to drive their success and reputation as a trusted source for vitamin K2 solutions.
DitchCarbon Score
How does Kappa Bioscience AS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kappa Bioscience AS's score of 14 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kappa Bioscience AS's reported carbon emissions
Kappa Bioscience AS, headquartered in Norway, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor Kappa Bioscience AS for future updates regarding their climate commitments and any potential strategies they may implement to reduce their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kappa Bioscience AS is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
